Greg Fliszar joined the Hospital Finance Podcast to discuss the ongoing legal battle between the U.S. government and the hospital industry. The program allows certain health care providers to purchase outpatient drugs at discounted prices, which they are then required to pass on to patients. However, drug manufacturers have been accused of underpaying the government for these drugs, and the government is seeking billions of dollars in damages.

To listen to the podcast, click here.